Last close As at 01/09/2026
ZAR28.77
▲ 0.32 (1.12%)
Market capitalisation
ZAR12,142m
Research: TMT
Altron’s pre-close update confirmed that trading in the first five months of FY27 has broadly been in line with management expectations and is expected to continue in a similar vein for the rest of FY27. The Platforms segment is trading ahead of our expectations, offset by weaker performance in IT Services, mainly from Altron Security. We have revised our forecasts to reflect this weighting, with Platforms continuing to generate a growing proportion of operating profit.
| Year end | Revenue (ZARm) | PBT (ZARm) | EPS (ZAR) | HEPS (ZAR) | DPS (ZAR) | P/E (x) | Yield (%) |
|---|---|---|---|---|---|---|---|
| 2/25 | 9,588.0 | 912.0 | 1.83 | 1.78 | 0.90 | 15.6 | 3.2 |
| 2/26 | 9,637.0 | 1,173.0 | 2.34 | 2.39 | 2.40 | 12.2 | 8.4 |
| 2/27e | 10,258.3 | 1,288.0 | 2.32 | 2.36 | 1.14 | 12.3 | 4.0 |
| 2/28e | 10,887.1 | 1,457.0 | 2.58 | 2.56 | 1.24 | 11.0 | 4.4 |
For the five months ended 31 July 2026 (5M27), Altron’s continuing operations saw revenue growth in the low-single digits and EBITDA and operating profit growth in the low-to-mid teens. Platforms revenue growth was in the high-single digits, and IT Services saw modest growth (we assume low-single digit). The Distribution business saw strong momentum and a book-to-bill above 1x. All Platforms businesses increased EBITDA by at least the mid-teens y-o-y. Group operating margin expanded year-on-year and the company closed the five-month period in a net cash position, even after paying the special dividend.
We have revised our forecasts to reflect the relative performance of the three segments: we upgrade Platforms and Distribution revenue and profitability, offset by weaker IT Services expectations. Our operating profit forecast reduces by 5% in FY27 and is broadly unchanged in FY28. We have also updated our forecasts to reflect a slightly higher tax rate in FY27 and the recent issue of performance shares. Our basic continuing HEPS forecast reduces by 8.7% in FY27 and 3.8% in FY28. Management continues to focus on driving the organic growth of the group, directing investment at high-margin, annuity-based growth opportunities, including Netstar’s platform modernisation, and the expansion of Altron FinTech.
Using a sum-of-the-parts valuation on our revised forecasts and after a 30% holding company/South Africa discount, we arrive at a valuation of ZAR33.8 per share (marginally up from ZAR33.2 when we last wrote), 19% above the current share price. The increased proportion of profits from the Platforms businesses has more than offset the effect of the higher share count. In our view, evidence of continued progress towards medium-term operating margin targets, including sustained recovery in ADB revenue and margins, would be the key driver of share price upside.
On 31 August, Altron provided an update on trading year to date. The commentary on financial performance covers continuing operations for the five months to 31 July 2026 (5M27) compared to the same period a year ago (5M26).
Trading and operational performance for 5M27 has been broadly in line with management expectations and the group expects trading for H127 to follow a similar trend.
Group revenue growth for 5M27 was in the low-single digits, and the company expects to see a similar pattern in FY27 as in FY26, with H227 performance expected to be stronger than in H127.
Group EBITDA and operating profit increased by low-to-mid-teen percentages. The group operating margin was higher year-on-year for 5M27 reflecting operating leverage in the Platforms business and improved profitability in the IT Services segment.
The company maintained a positive net cash position and an ungeared balance sheet, having made dividend payments of ZAR750m in June (this comprised the ZAR0.72 final dividend and ZAR1.20 special dividend).
The Platforms segment delivered high-single-digit revenue growth in 5M27 and made up c 45% of group revenue while accounting for c 95% of operating profit.
The IT Services segment delivered modest revenue growth in 5M27, and profitability improved as Altron Digital Business returned to profitability.
Altron Arrow had a strong start to the year, entering FY27 with positive momentum. The company believes the business has moved through the bottom of the cycle, and the business now has a growing order book. Book-to-bill was above 1x during 5M27, for the first time in two years.
The company noted that it has undertaken a comprehensive reassessment of broad-based black economic empowerment (B-BBEE) ownership usage methodology. This has resulted in a re-rating of its Black Owned status, from 63% overall (up from 38%), and for Black Women Owned status, from 21% to 35%. These ownership credentials flow through to the relevant South African operating entities, taking them above key ownership thresholds and strengthening their competitiveness in government and enterprise procurement. This also provides Altron with better flexibility in achieving targeted B-BBEE outcomes, meaning that it can increasingly direct investment towards initiatives that deliver meaningful and sustainable impact.
Management confirmed that trading and operational performance in 5M27 was broadly in line with its expectations, and it expects trading for H227 to follow a similar trend. We have made the following changes to our forecasts:
At a group level, this results in revenue growth for FY27 declining slightly from 6.6% to 6.4%. EBITDA growth reduces from 14.2% to 10.2% with the margin decreasing from 22.2% to 21.5%. This drops through to operating profit growth of 8.0% (down from 14.0%) and an operating margin of 12.8% (down from 13.5%). We have increased our tax rate assumption from 25% to 27% in FY27 – we had assumed this would be a transition year to the standard 27% rate, but management confirmed that the full amount is likely to apply for FY27. We have also factored in a higher share count to reflect shares issued so far in FY27. Basic continuing HEPS for FY27 decreases from ZAR2.59 to ZAR2.36 and for FY28 from ZAR2.67 to ZAR2.56.
General disclaimer and copyright
This report has been commissioned by Altron and prepared and issued by Edison, in consideration of a fee payable by Altron. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.
Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.
Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.
No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.
Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.
Copyright 2026 Edison Investment Research Limited (Edison).
Australia
Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.
New Zealand
The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.
United Kingdom
This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.
This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.
This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.
United States
Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.
London │ New York │ Frankfurt
20 Red Lion Street
London, WC1R 4PS
United Kingdom
Research: Healthcare
Newron has announced the completion of screening for its pivotal Phase III ENIGMA-TRS 1 study of evenamide in treatment-resistant schizophrenia (TRS), marking an important milestone. A total of 996 patients have entered screening, with 411 already randomised and 352 still progressing through the 42-day screening assessment. Based on current eligibility rates, Newron expects at least another 200 patients to be randomised, taking the study beyond its protocol target of 600 patients from mid-October. Top-line results from the primary 12-week treatment period are anticipated in Q127, a slight adjustment from prior guidance of Q426. We do not view this modest timing shift as materially changing the investment case. The completion of screening provides increased visibility on delivery of the required study population and brings the first pivotal efficacy readout for evenamide into view. The Q127 readout represents a key potential upcoming catalyst.